| **Segment, Geographic and Other Revenue Information - Schedules of Concentration of Risk (Details) - Revenue [Member] - Customer Concentration Risk [Member]** | 12 Months Ended |
|----------------------------------------------------------------------------------------------------------------------------------------------------------------|-----------------|
||
| McKesson, Inc. [Member]                                                                                                                                        |            |   |   |
| **Concentration Risk [Line Items]**                                                                                                                            |            |   |   |
| Concentration risk, percentage                                                                                                                                 | 17.00%          | 8.00% | 9.00% |
| Cencora, Inc. (formerly AmerisourceBergen Corporation) [Member]                                                                                                |            |   |   |
| **Concentration Risk [Line Items]**                                                                                                                            |            |   |   |
| Concentration risk, percentage                                                                                                                                 | 12.00%          | 5.00% | 7.00% |
| Cardinal Health, Inc. [Member]                                                                                                                                 |            |   |   |
| **Concentration Risk [Line Items]**                                                                                                                            |            |   |   |
| Concentration risk, percentage                                                                                                                                 | 10.00%          | 4.00% | 5.00% |
| US Government [Member]                                                                                                                                         |            |   |   |
| **Concentration Risk [Line Items]**                                                                                                                            |            |   |   |
| Concentration risk, percentage                                                                                                                                 | 0.00%           | 23.00% | 13.00% |

| X                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                       |
|-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| - Definition
Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.
+ References
Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Topic 954 -SubTopic 310 -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Publisher FASB -URI https://asc.fasb.org//1943274/2147481027/954-310-50-2
+ Details**Name:**us-gaap_ConcentrationRiskLineItems**Namespace Prefix:**us-gaap_**Data Type:**xbrli:stringItemType**Balance Type:**na**Period Type:**duration |
| X                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                       |
|---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| - Definition
For an entity that discloses a concentration risk in relation to quantitative amount, which serves as the "benchmark" (or denominator) in the equation, this concept represents the concentration percentage derived from the division.
+ References
Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Topic 280 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 42 -Publisher FASB -URI https://asc.fasb.org//1943274/2147482810/280-10-50-42Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Topic 825 -SubTopic 10 -Section 50 -Paragraph 21 -Subparagraph (a) -Publisher FASB -URI https://asc.fasb.org//1943274/2147482907/825-10-50-21Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Topic 825 -SubTopic 10 -Section 50 -Paragraph 20 -Publisher FASB -URI https://asc.fasb.org//1943274/2147482907/825-10-50-20Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Topic 275 -SubTopic 10 -Section 50 -Paragraph 18 -Publisher FASB -URI https://asc.fasb.org//1943274/2147482861/275-10-50-18Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Topic 275 -SubTopic 10 -Section 50 -Paragraph 20 -Publisher FASB -URI https://asc.fasb.org//1943274/2147482861/275-10-50-20
+ Details**Name:**us-gaap_ConcentrationRiskPercentage1**Namespace Prefix:**us-gaap_**Data Type:**dtr-types:percentItemType**Balance Type:**na**Period Type:**duration |
| X                                                                                                                                     |
|---------------------------------------------------------------------------------------------------------------------------------------|
| - Details**Name:**srt_MajorCustomersAxis=pfe_McKessonInc.Member**Namespace Prefix:****Data Type:**na**Balance Type:****Period Type:** |
| X                                                                                                                                                                              |
|--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| - Details**Name:**us-gaap_ConcentrationRiskByBenchmarkAxis=us-gaap_RevenueFromContractWithCustomerMember**Namespace Prefix:****Data Type:**na**Balance Type:****Period Type:** |
| X                                                                                                                                                                   |
|---------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| - Details**Name:**us-gaap_ConcentrationRiskByTypeAxis=us-gaap_CustomerConcentrationRiskMember**Namespace Prefix:****Data Type:**na**Balance Type:****Period Type:** |
| X                                                                                                                                                                        |
|--------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| - Details**Name:**srt_MajorCustomersAxis=pfe_CencoraInc.FormerlyAmerisourceBergenCorporationMember**Namespace Prefix:****Data Type:**na**Balance Type:****Period Type:** |
| X                                                                                                                                           |
|---------------------------------------------------------------------------------------------------------------------------------------------|
| - Details**Name:**srt_MajorCustomersAxis=pfe_CardinalHealthInc.Member**Namespace Prefix:****Data Type:**na**Balance Type:****Period Type:** |
| X                                                                                                                                     |
|---------------------------------------------------------------------------------------------------------------------------------------|
| - Details**Name:**srt_MajorCustomersAxis=pfe_USGovernmentMember**Namespace Prefix:****Data Type:**na**Balance Type:****Period Type:** |
| X                                                                                                                                                              |
|----------------------------------------------------------------------------------------------------------------------------------------------------------------|
| - Details**Name:**us-gaap_ConcentrationRiskByBenchmarkAxis=us-gaap_SalesRevenueNetMember**Namespace Prefix:****Data Type:**na**Balance Type:****Period Type:** |